We are live on ! Find out more
GNPX icon

Genprex

16 hedge funds and large institutions have $2.6M invested in Genprex in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1616 (0)

0% more ownership

Funds ownership: 0%0% (+0%)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

28% less capital invested

Capital invested by funds: $3.6M → $2.6M (-$1.01M)

Holders
16
Holders Change
Holders Change %
0%
% of All Funds
0.25%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
2
Reduced
Closed
3
Calls
$5K
Puts
Net Calls
+$5K
Net Calls Change
-$43K

GNPX Hedge Fund Activity: Q3 2023 in Review

16 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q3 2023, worth a combined $2.6M — down 28% from $3.6M a quarter earlier.

Fund positioning in GNPX was balanced in Q3 2023: 3 funds opened new positions, 3 closed out, 2 added to existing stakes and 0 trimmed.

The largest buyer was CVI Holdings, opening a new position worth an estimated $1.24M. The largest seller was Rockefeller Capital Management, exiting entirely with an estimated $142K sold.

  • 16 institutional investors held Genprex (GNPX) as of Q3 2023, unchanged from Q2 2023.
  • Funds reported $2.6M of Genprex stock for Q3 2023, down 28% quarter-over-quarter.
  • 3 funds opened new Genprex positions in Q3 2023 and 3 closed out, a net change of 0 holders.
  • The largest Genprex buyer in Q3 2023 was CVI Holdings, an estimated $1.24M added.
  • The largest Genprex seller in Q3 2023 was Rockefeller Capital Management, an estimated $142K sold.

Based on aggregated 13F filings for Q3 2023.